跳至主要内容
临床试验/NCT02150564
NCT02150564已完成不适用

Role of 3-D Navigable Ultrasound in Resection of Intra-axial Brain Tumors - A Randomized Controlled Study

Tata Memorial Hospital2 个研究点 分布在 1 个国家目标入组 72 人开始时间: 2014年3月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
72
试验地点
2
主要终点
Percentage of patients where Gross total resection (GTR) achieved

研究概览

简要总结

Phase 3 randomized open labeled trials will evaluate the 3 D navigable ultrasound (SonoWand) in improving the extent of resection in intra-axial brain tumors. All patients will undergo resective surgery. In the experimental arm, a navigable 3 D ultrasound will be used. In the standard arm, only navigation will be used. This study will help in assessing the usefulness sononavigation in improving radicality of resection in malignant gliomas and also to access the accuracy of SonoWand in predicting residue (histopathological correlation).

详细描述

Routine presurgical evaluation of all patients will be conducted. The preoperative use of steroids, antiepileptics and other medications would be as per standard procedure and would be documented. In addition detailed MRI evaluation will be performed (including contrast enhanced MRI study, diffusion MRI, perfusion MR, MR spectroscopy, dynamic-contrast-enhanced MRI for permeability studies, as well as functional MRI, and tractography if required) not more than 1 week prior to the date of surgery.

Navigation specific MR sequences would be performed in all patients (both arms).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • All radiologically-suspected, previously untreated, supratentorial malignant gliomas being considered for debulking surgery.
  • Adults (above 18 years)
  • Eligible for surgical therapy (craniotomy not stereotactic biopsy )
  • Resectability : A lesion would be considered "resectable" if the surgeons feel that all the radiologically imaged lesion can be removed (with reasonable certainty). Only deemed resectable lesions will be included

排除标准

  • Unfit for GA
  • Unwilling for the study
  • Unresectable lesion

结局指标

主要结局

Percentage of patients where Gross total resection (GTR) achieved

时间窗: Post operative within 72 hrs.

Measure: Volumetric MRI - residual tumor (in cc)

次要结局

  • Accuracy of US(Post operative within 72 hrours)

研究者

申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Dr Aliasgar V Moiyadi

Prof and Neurosurgeon

Tata Memorial Hospital

研究点 (2)

Loading locations...

相似试验